Literature DB >> 6508265

Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli.

W L Wang, L B Reller, M J Blaser.   

Abstract

To determine whether employing antibiograms is useful to separate Campylobacter jejuni and Campylobacter coli, we determined the MICs of 12 antibiotics for 104 human clinical strains and 74 swine strains. Of 74 swine strains, 5 (7%) were hippurate positive, as were 93 (89%) of 104 human strains. The 12 antimicrobial agents tested were ampicillin, amoxicillin, clindamycin, chloramphenicol, erythromycin, furazolidone, norfloxacin, nalidixic acid, rosoxacin, rosaramicin, tetracycline, and Sch 32063. Isolates from humans were significantly (P less than 0.001) more susceptible than swine strains to clindamycin, erythromycin, rosaramicin, and Sch 32063. Of 11 human hippurate-negative strains, 3 (27%) were resistant to clindamycin, erythromycin, rosaramicin, and Sch 32063, compared with 1 of 93 (1%) hippurate-positive strains. Nearly all human and swine strains were susceptible to furazolidone and nalidixic acid. Campylobacter isolates from humans and swine have different antibiograms, and the susceptibility to certain antibiotics, such as clindamycin, may be helpful for differentiation of C. jejuni from C. coli.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6508265      PMCID: PMC176168          DOI: 10.1128/AAC.26.3.351

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  Campylobacter enteritis.

Authors:  J P Butzler; M B Skirrow
Journal:  Clin Gastroenterol       Date:  1979-09

Review 2.  The genus Campylobacter.

Authors:  R M Smibert
Journal:  Annu Rev Microbiol       Date:  1978       Impact factor: 15.500

3.  Erythromycin-resistant campylobacters.

Authors:  W A Brunton; A M Wilson; R M Macrae
Journal:  Lancet       Date:  1978 Dec 23-30       Impact factor: 79.321

4.  Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.

Authors:  R Vanhoof; M P Vanderlinden; R Dierickx; S Lauwers; E Yourassowsky; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

5.  Campylobacter arthritis.

Authors:  J K Kowalec; Z C Kaminski; P R Krey
Journal:  Arthritis Rheum       Date:  1980-01

6.  Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents.

Authors:  M Walder
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

7.  Hippurate hydrolysis by Campylobacter fetus.

Authors:  S M Harvey
Journal:  J Clin Microbiol       Date:  1980-04       Impact factor: 5.948

8.  Acute colitis caused by Campylobacter fetus ss. jejuni.

Authors:  M J Blaser; R B Parsons; W L Wang
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

9.  '1001' Campylobacters: cultural characteristics of intestinal campylobacters from man and animals.

Authors:  M B Skirrow; J Benjamin
Journal:  J Hyg (Lond)       Date:  1980-12

10.  Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni.

Authors:  R Vanhoof; B Gordts; R Dierickx; H Coignau; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

View more
  22 in total

1.  Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998.

Authors:  Y Sáenz; M Zarazaga; M Lantero; M J Gastanares; F Baquero; C Torres
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila.

Authors:  P Hohl; A von Graevenitz; J Zollinger-Iten
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

3.  Characterization of an unclassified microaerophilic bacterium associated with gastroenteritis.

Authors:  J R Archer; S Romero; A E Ritchie; M E Hamacher; B M Steiner; J H Bryner; R F Schell
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

4.  Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients.

Authors:  J Reina; M J Ros; A Serra
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

5.  Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.

Authors:  N Lachance; C Gaudreau; F Lamothe; F Turgeon
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

6.  In vitro susceptibilities of Campylobacter jejuni and Campylobacter coli to azithromycin and erythromycin.

Authors:  D E Taylor; N Chang
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

7.  Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin.

Authors:  H Adler-Mosca; J Lüthy-Hottenstein; G Martinetti Lucchini; A Burnens; M Altwegg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

Review 8.  Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; D M Richards
Journal:  Drugs       Date:  1985-12       Impact factor: 9.546

9.  Characterization of erythromycin resistance in Campylobacter jejuni and Campylobacter coli.

Authors:  W Yan; D E Taylor
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

10.  Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland.

Authors:  H Rautelin; O V Renkonen; T U Kosunen
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.